title: Ustekinumab (Stelara) for Crohn's disease.
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D003424:Crohn Disease / Q000188:drug therapy* / Q000378:metabolism; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D018664:Interleukin-12 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D053759:Interleukin-23 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000069549:Ustekinumab / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D053759:Interleukin-23; D018664:Interleukin-12; D000069549:Ustekinumab